Current applications of nanoparticles in infectious diseases

H Zazo, CI Colino, JM Lanao - Journal of Controlled Release, 2016 - Elsevier
For decades infections have been treated easily with drugs. However, in the 21st century,
they may become lethal again owing to the development of antimicrobial resistance …

Nanomaterials for application in wound Healing: Current state-of-the-art and future perspectives

MA Shalaby, MM Anwar, H Saeed - Journal of Polymer Research, 2022 - Springer
Nanoparticles are the gateway to the new era in drug delivery of biocompatible agents.
Several products have emerged from nanomaterials in quest of developing practical wound …

Polymeric nanoparticles of Brazilian red propolis extract: preparation, characterization, antioxidant and leishmanicidal activity

TG Do Nascimento, PF Da Silva, LF Azevedo… - Nanoscale research …, 2016 - Springer
The ever-increasing demand for natural products and biotechnology derived from bees and
ultra-modernization of various analytical devices has facilitated the rational and planned …

[HTML][HTML] Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis–A review

P Prasanna, P Kumar, S Kumar, VK Rajana… - Biomedicine & …, 2021 - Elsevier
The study of tropical diseases like leishmaniasis, a parasitic disease, has not received much
attention even though it is the second-largest infectious disease after malaria. As per the …

Extracellular matrix component-derived nanoparticles for drug delivery and tissue engineering

KJ Hogan, MR Perez, AG Mikos - Journal of Controlled Release, 2023 - Elsevier
The extracellular matrix (ECM) consists of a complex combination of proteins, proteoglycans,
and other biomolecules. ECM-based materials have been demonstrated to have high …

Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases

JS Lanza, S Pomel, PM Loiseau… - Expert opinion on drug …, 2019 - Taylor & Francis
Introduction: Among the drugs in clinical use for the treatment of leishmaniases,
amphotericin B (AmB) is the most effective and has been the most extensively studied for the …

Promising nanotherapy in treating leishmaniasis

A de Souza, DSS Marins, SL Mathias… - International Journal of …, 2018 - Elsevier
Leishmaniases are infectious diseases caused by an intracellular protozoan in humans by
20 different species of Leishmania among more than 53 species. There are at least twelve …

Activity of amphotericin B-loaded chitosan nanoparticles against experimental cutaneous leishmaniasis

A Riezk, K Van Bocxlaer, V Yardley, S Murdan, SL Croft - Molecules, 2020 - mdpi.com
Chitosan nanoparticles have gained attention as drug delivery systems (DDS) in the medical
field as they are both biodegradable and biocompatible with reported antimicrobial and anti …

New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment

MA Chávez-Fumagalli, TG Ribeiro… - Revista da Sociedade …, 2015 - SciELO Brasil
Leishmaniasis is one of the six major tropical diseases targeted by the World Health
Organization. It is a life-threatening disease of medical, social and economic importance in …

Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport

LQ Jiang, TY Wang, TJ Webster, HJ Duan… - International journal …, 2017 - Taylor & Francis
Biodegradable nanomaterials have been widely used in numerous medical fields. To further
improve such efforts, this study focused on the intracellular disposition of chitosan …